139 related articles for article (PubMed ID: 34781143)
1. Carminic acid mitigates fructose-triggered hepatic steatosis by inhibition of oxidative stress and inflammatory reaction.
Li L; Fang B; Zhang Y; Yan L; He Y; Hu L; Xu Q; Li Q; Dai X; Kuang Q; Xu M; Tan J; Ge C
Biomed Pharmacother; 2022 Jan; 145():112404. PubMed ID: 34781143
[TBL] [Abstract][Full Text] [Related]
2. Carminic acid supplementation protects against fructose-induced kidney injury mainly through suppressing inflammation and oxidative stress via improving Nrf-2 signaling.
Li Q; Xu Q; Tan J; Hu L; Ge C; Xu M
Aging (Albany NY); 2021 Apr; 13(7):10326-10353. PubMed ID: 33819919
[TBL] [Abstract][Full Text] [Related]
3. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
[TBL] [Abstract][Full Text] [Related]
4. 18α-Glycyrrhetinic acid (GA) ameliorates fructose-induced nephropathy in mice by suppressing oxidative stress, dyslipidemia and inflammation.
Cheng X; Qiu L; Wang F
Biomed Pharmacother; 2020 May; 125():109702. PubMed ID: 32106383
[TBL] [Abstract][Full Text] [Related]
5. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
[TBL] [Abstract][Full Text] [Related]
6. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
[TBL] [Abstract][Full Text] [Related]
7. Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia.
Xu MX; Ge CX; Qin YT; Gu TT; Lou DS; Li Q; Hu LF; Feng J; Huang P; Tan J
Free Radic Biol Med; 2019 Jan; 130():542-556. PubMed ID: 30465824
[TBL] [Abstract][Full Text] [Related]
8. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
9. HDAC11 deletion reduces fructose-induced cardiac dyslipidemia, apoptosis and inflammation by attenuating oxidative stress injury.
Fan XD; Wan LL; Duan M; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(2):444-451. PubMed ID: 29655790
[TBL] [Abstract][Full Text] [Related]
10. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
Wu L; Liu Y; Zhao Y; Li M; Guo L
Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
[TBL] [Abstract][Full Text] [Related]
11. Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING.
Li YN; Su Y
Biochem Biophys Res Commun; 2020 May; 526(2):381-388. PubMed ID: 32223926
[TBL] [Abstract][Full Text] [Related]
12. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
13. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP
Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520
[TBL] [Abstract][Full Text] [Related]
14. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
[TBL] [Abstract][Full Text] [Related]
15. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
16. Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway.
Qu LL; Yu B; Li Z; Jiang WX; Jiang JD; Kong WJ
Phytother Res; 2016 Mar; 30(3):402-11. PubMed ID: 26634892
[TBL] [Abstract][Full Text] [Related]
17. Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARα/AdipoR2, in vivo and in vitro.
Chen J; Liu J; Wang Y; Hu X; Zhou F; Hu Y; Yuan Y; Xu Y
Biomed Pharmacother; 2017 Jul; 91():621-631. PubMed ID: 28486193
[TBL] [Abstract][Full Text] [Related]
18. (-)-Hydroxycitric Acid Alleviates Oleic Acid-Induced Steatosis, Oxidative Stress, and Inflammation in Primary Chicken Hepatocytes by Regulating AMP-Activated Protein Kinase-Mediated Reactive Oxygen Species Levels.
Li L; Chu X; Yao Y; Cao J; Li Q; Ma H
J Agric Food Chem; 2020 Oct; 68(40):11229-11241. PubMed ID: 32940033
[TBL] [Abstract][Full Text] [Related]
19. Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress.
Li C; Liu Q; Xie L
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):22-29. PubMed ID: 30454891
[TBL] [Abstract][Full Text] [Related]
20. Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice.
Yang HJ; Tang LM; Zhou XJ; Qian J; Zhu J; Lu L; Wang XH
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):619-25. PubMed ID: 26663010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]